Incidence and Predictors of Persistent Left Atrial Appendage Patency and its Subtypes after Percutaneous Closure: a Pre-Specified Analysis of the SWISS-APERO Trial

Atrial Fibrillation

3-Year Clinical Outcomes Comparing the Amulet vs Watchman FLX for Left Atrial Appendage Closure in Patients With Atrial Fibrillation: Results From the SWISS-APERO Randomized Clinical Trial

J Am Coll Cardiol

Galea R, De Marco F, Aminian A, Meneveau N, Chalkou K, Anselme F, Gräni C, Franzone A, Vranckx P, Fischer U, Valgimigli M, Räber L

doi: 10.1016/j.jacc.2025.03.535

Atrial FibrillationThrombosis and Stroke

Left Atrial Appendage Closure versus Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Long-Term Outcomes from Four Randomized Trials

Heart Rhythm

Kaisaier W, Xu Z, Guo L, Dong Y, Chen Y, Lip GYH, Zhu W

doi: 10.1016/j.hrthm.2025.07.051

Atrial FibrillationTherapy and Intervention

Rationale and design of the Anticoagulant Therapy after Left Atrial Appendage Closure (ATLAAC) Trial

Am Heart J

Gosvig K, Goller J, Hansson NH, Brandes A, Modrau I, Rasmussen LF, Eskesen K, Jensen AKG, Belley-Côté E, Whitlock R, Riber LPS

doi: 10.1016/j.ahj.2025.04.015

Therapy and Intervention

Single versus Dual Antiplatelet Therapy after Left Atrial Appendage Closure: a Propensity Score Matching Analysis

Heart Rhythm

Galea R, Krsnik JP, Bini T, Chalkou K, Gasys A, Brugger N, Madhkour R, Seiffge DJ, Roten L, Siontis GCM, Räber L

doi: 10.1016/j.hrthm.2024.12.007

Thrombosis and Stroke

Ischemic outcomes after left atrial appendage closure following intracerebral hemorrhage: a retrospective inverse probability weighting analysis from the HANSE-LAAC registry

Clin Res Cardiol

Jurczyk D, Mezger M, Lemmer F, Fatum C, Gradaus R, Drochner-Brocks NK, Saraei R, Frerker C, Stiermaier T, Paitazoglou C, Eitel I

doi: 10.1007/s00392-025-02668-7

Thrombosis and Stroke

Impact of Peridevice Leak on Clinical Outcomes After Left Atrial Appendage Closure: The OCEAN-LAAC Registry

J Am Heart Assoc

Saito T, Tsuruta H, Kajino A, Iwata J, Sakata S, Ryuzaki T, Sago M, Tanaka S, Chatani R, Hachinohe D, Naganuma T, Ohno Y, Tani T, Okamatsu H, Mizutani K, Watanabe Y, Izumo M, Saji M, Mizuno S, Ueno H, Kubo S, Shirai S, Nakashima M, Asami M, Yamamoto M, Ieda M, Hayashida K, OCEAN‐LAAC investigators

doi: 10.1161/JAHA.125.044422

Atrial FibrillationTherapy and Intervention

Left Atrial Appendage Closure in Patients Refusing Oral Anticoagulation: The LAAC-REFUSAL Study

J Am Heart Assoc

Galea R, Bini T, Korsholm K, Sedaghat A, Aminian A, Vij V, Perich Krsnik J, Chalkou K, Siontis G, Roten L, Nielsen-Kudsk JE, Räber L

doi: 10.1161/JAHA.124.040404

Atrial FibrillationThrombosis and Stroke

Left atrial appendage occlusion: trends in demographics and in-hospital outcomes-a German nationwide analysis

Clin Res Cardiol

Voran JC, Seoudy H, Leye M, Kolbrink B, Schulte K, Dempfle A, Frank D, Kreidel F

doi: 10.1007/s00392-024-02586-0

Heart, Artery and Coronary Diseases

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial

Eur J Heart Fail

Petrie MC, Udell JA, Anker SD, Harrington J, Jones WS, Mattheus M, Gasior T, van der Meer P, Amir O, Bahit MC, Bauersachs J, Bayes-Genis A, Chopra VK, Januzzi JL, Lopes RD, Ponikowski P, Rossello X, Schou M, Zieroth S, Brueckmann M, Sumin M, Bhatt DL, Hernandez AF, Butler J

doi: 10.1002/ejhf.3548

Related content